Table 1 Demographic and clinical characteristics of enrolled systemic sclerosis patients
From: Correlation of retinal and choroidal microvascular impairment in systemic sclerosis
Parameter | Distribution or median (min–max) |
|---|---|
Gender (female/male) | 11/4 |
Age (years) | 63 (49–77) |
Disease duration (months) | 60 (13–228) |
Classification (limited/diffuse cutaneous SSc) | 12/3 |
Vasodilatative comedication (Calcium channel blockers; Phosphodiesterase type 5 inhibitor inhibitors; Endothelin receptor antagonist; Prostacyclin analogue) | 13/15 |
Immunosuppressive comedication (Methotrexate; Mycophenolate mofetil; Azathioprine; Hydroxychloroquine) | 12/15 |
Modified Rodnan Skin Score (0–51) | 6 (2–24) |
Raynaud + | 15/15 |
History of digital ulcers | 12/15 |
Capillaroscopic skin ulcer risk Index | 0.6 (0–41.7) |
Arthritis | 8/15 |
Pulmonary fibrosis | 9/15 |
Erythrocyte sedimentation rate (mm) | 18 (12–60) |
C-Reactive protein (mg/l) | 5.1 (0.9–16.6) |
ANA + | 15/15 |
Anti-RNA polymerase III + | 3/15 |
Anti-centromere + | 7/15 |
Anti-Scl70 + | 6/15 |